GSK Stockmann advised the owners and founders of SCiLS GmbH, Bremen, on the sale of their shares to Bruker Daltonik GmbH.

SCiLS, founded as a spin-off of the University of Bremen and winner of the 2015 Founders Prize, develops innovative software tools such as statistical analysis software, sophisticated visualization systems and secure cloud-based services for the collaborative interpretation of complex data sets for the imaging industry mass spectrometry (MSI). The combination of the advanced SCiLS software tools with Bruker's high-resolution MALDI-MSI imaging systems allows a deeper understanding of the spatial distribution of various molecules ranging from “Biomarker”- discovery to translational research in histopathology and other future diagnostic applications.

GSK Stockmann advised the owners of SCiLS on all legal aspects regarding the sale of their shares.

Advisor to Founder and Owner of SCiLS GmbH:
GSK STOCKMANN: Dr. Markus Söhnchen (Lead), Dr. Gerhard Gündel (both Cor-porate/M&A); Associates: Inga Henrich (Corporate/M&A), Martin Hossenfelder (IP/IT).